AHA Scientific Sessions 2017, Nov 11-15

The American Heart Association's Scientific Sessions 2017 is one of the most prominent meetings in USA on the topic and is optimal to acquire the latest information about Medical, Heart Care, Health Care, Cardiology, Cardiovascular and Heart Diseases.

Bioneer will be sharing our knowhow and contributions to the CarTarDis FP7-project, showcasing Bioneer's state-of-the-art technologies within molecular imaging and staining, both essential for validating novel molecular drug targets. The focus for CarTarDis has been to identify and validate new drug targets for treatment of atherosclerotic plaques. 

Learn more at the poster session on November 12, 3:15pm-4:30pm, where Bioneer will present the poster "In situ Multimodal Molecular Imaging and Staining Technologies Supporting Target Validation in Cardiovascular Disease"

Bioneer will be represented by R&D Managers Kim Holmstrøm (kho [at] and Boye Schnack Nielsen (bsn [at]

Find out more about the meeting here.